Newsroom | 8767 results

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran and his TeamBest Global family of companies—recognized innovators in cost-effective technologies for the diagnosis/treatment of cancer and vascular diseases, including theranostics—have issued an open call for deeper collaboration with the Association of Radiation Oncologists of India (AROI). Suthanthiran founded the International Society of Therapeutic Radiology and Oncology (ISTRO) under the Best Cure Foundation (BCF) and the Brachytherap...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application...

DUBLIN--(BUSINESS WIRE)--The "Protein Chip Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global protein chip market is poised for remarkable growth, with its size projected to expand from USD 2.15 billion in 2024 to USD 4.14 billion by 2033. This corresponds to a compound annual growth rate (CAGR) of 7.74% from 2025 to 2033. Driving this growth are factors such as the increasing prevalence of chronic diseases, including cancer, cardiovascular, and neurologica...

DENVER--(BUSINESS WIRE)--Cleerly, a leader in AI-based cardiovascular imaging, will showcase new product updates at RSNA 2025, November 30 - December 4, 2025, at McCormick Place in Chicago, IL. At Booth #8039, Cleerly will demonstrate PowerScribe integration and newly added lesion-level reporting, discuss new clinical research findings, and provide guidance on the plaque analysis Category I CPT code effective January 1, 2026. The PowerScribe integration will help simplify clinic workflows by ma...

TAMPA, Fla.--(BUSINESS WIRE)--The following is an opinion editorial provided by Casey Pittock, CEO, Smart Meter: UnitedHealthcare’s decision to sharply limit remote patient monitoring (RPM) reimbursement beginning January 1, 2026, to heart failure and hypertensive disorders of pregnancy, is a disservice to clinicians, patients, and the healthcare system at large. It contradicts federal momentum to modernize chronic care and misrepresents the weight of current evidence on RPM’s clinical value fo...

HENDERSON, Nev.--(BUSINESS WIRE)--Corstasis Therapeutics Inc., a commercial-stage biopharmaceutical company advancing innovative outpatient therapies for cardiovascular and renal disease, today announced that it is working with Cardiovascular Logistics (CVL) to support the clinical adoption and integration of ENBUMYST™ (bumetanide nasal spray) into modern heart failure management pathways, consistent with FDA-approved use in outpatient heart failure care. The initiative is designed to improve a...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2025 fiscal year ended September 30, 2025. The Company is hosting a conference call today, November 25, 2025, at 4:30 p.m. ET to discuss the results. “The recent FDA approval of REDEMPLO, indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), is a transformational milestone for Arrowhead. REDEMPLO is the first and on...

TORONTO--(BUSINESS WIRE)--Vasomune Therapeutics and AnGes Commit to Development of Additional Indications for Pegevongitide (AV-001)....

DURHAM, N.C.--(BUSINESS WIRE)--Target RWE announces real-world evidence showing Repatha’s long-term cardiovascular benefits....

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Alex Shvartsburg, Chief Financial Officer, will present a general business update during a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York City. The presentation will take place on Tues., Dec. 2, at 1:30 p.m. Eastern Standard Time. The discussion will be available to all interested parties who register to attend the webcast, which is accessible...